sec filing
ON
NASDAQ · ONMDW
OneMedNet Corporation
Technology · Software - Application
$0.01
Down-$0.00 (-15.08%)
Updated Nov 5, 2026, 8:24 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 133.39M
- P/E ratio
- -41.37
- Dividend yield
- 0.00%
- 52-week range
- $0.02 – $0.07
- Volume
- 6K
- Avg. volume
- 43.84K
Price performance · ONMDW
ONMDW price history
1M range · 6 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
ONMDW closed at $0.01 after 6 trading sessions, down 58.19% for the selected period.
- Last close
- $0.01
- Period change
- -58.19%
- Period low
- $0.01
- Period high
- $0.03
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $0.0158 | $0.0158 | $0.0125 | $0.0125 | 6K |
| Nov 3, 2026 | $0.0159 | $0.0159 | $0.0159 | $0.0159 | 850 |
| Oct 29, 2026 | $0.0225 | $0.0225 | $0.018 | $0.018 | 23.43K |
| Oct 27, 2026 | $0.019 | $0.0191 | $0.019 | $0.0191 | 2.8K |
| Oct 26, 2026 | $0.019 | $0.019 | $0.019 | $0.019 | 265 |
| Oct 19, 2026 | $0.0193 | $0.0299 | $0.019 | $0.0299 | 5.1K |
Latest ONMDW news
The latest Smart Investors Daily articles mentioning ONMDW.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ONMDW research
Overview
Company profile and research snapshot.
Company profile
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.